Come up with a name for your new list and we'll add to it:
Savara raised a round of funding on June 11, 2010. Investors include
Texas Emerging Technology Fund.
Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…